Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6250369 | 7036753 | I | 6250369-0 | 20090618 | 20090630 | EXP | PHHY2009GB25126 | NOVARTIS PHARMACEUTICALS CORP. | M | Y | 20090630 | OT | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6250369 | 1011810953 | PS | CLOZARIL | 1 | 100 MG MANE AND 300 MG NOCTE | 019758 | |||||
| 6250369 | 1011810954 | SS | CLOZARIL | 1 | 700 MG/DAY | 019758 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6250369 | 1011810953 | SCHIZOPHRENIA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6250369 | HO |
| 6250369 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6250369 | ANTIPSYCHOTIC DRUG LEVEL INCREASED |
| 6250369 | DRUG PRESCRIBING ERROR |
| 6250369 | ORTHOSTATIC HYPOTENSION |
| 6250369 | TREATMENT NONCOMPLIANCE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6250369 | 1011810953 | 19990505 | |||
| 6250369 | 1011810954 | 20090301 |